{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-037073","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.152482+00:00","generated_at":"2026-05-31T09:40:51.599023+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PDS Biotechnology enters $50M ATM equity offering program with B. Riley and H.C. Wainwright","bullets":["New at-the-market sales agreement allows up to $50M in common stock through B. Riley Securities and H.C. Wainwright.","Replaces prior August 2022 ATM program; 3% commission on gross proceeds to agents.","Shares sold via Rule 415 at-the-market on Nasdaq Capital Market; no minimum sales obligation.","Prior ATM agreement with B. Riley and BTIG terminated effective August 13, 2024.","Proceeds from any future sales will be used for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-037073","json":"https://secwatch.observer/filing/0001140361-24-037073.json","markdown":"https://secwatch.observer/filing/0001140361-24-037073.md","text":"https://secwatch.observer/filing/0001140361-24-037073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124037073/0001140361-24-037073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124037073/ny20034050x2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:40:51.599023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}